Annu Navani - 22 Sep 2025 Form 3 Insider Report for Semnur Pharmaceuticals, Inc. (DNQAF)

Role
Director
Signature
/s/ Stephen Ma, as attorney-in-fact
Issuer symbol
DNQAF
Transactions as of
22 Sep 2025
Net transactions value
$0
Form type
3
Filing time
26 Sep 2025, 16:10:03 UTC
Previous filing
19 Aug 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Navani Annu Director C/O SEMNUR PHARMACEUTICALS, INC., 960 SAN ANTONIO ROAD, PALO ALTO /s/ Stephen Ma, as attorney-in-fact 26 Sep 2025 0002033328

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.